BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38595736)

  • 41. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions.
    Johnson NW; Warnakulasuriya S; Gupta PC; Dimba E; Chindia M; Otoh EC; Sankaranarayanan R; Califano J; Kowalski L
    Adv Dent Res; 2011 May; 23(2):237-46. PubMed ID: 21490236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.
    Angadi PV; Rekha KP
    Oral Maxillofac Surg; 2011 Mar; 15(1):15-9. PubMed ID: 20414694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral cavity cancer in developed and in developing countries: population-based incidence.
    de Camargo Cancela M; Voti L; Guerra-Yi M; Chapuis F; Mazuir M; Curado MP
    Head Neck; 2010 Mar; 32(3):357-67. PubMed ID: 19644932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
    Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral submucous fibrosis: a case-control study in Chennai, South India.
    Ranganathan K; Devi MU; Joshua E; Kirankumar K; Saraswathi TR
    J Oral Pathol Med; 2004 May; 33(5):274-7. PubMed ID: 15078487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and functional staging of oral submucous fibrosis.
    Haider SM; Merchant AT; Fikree FF; Rahbar MH
    Br J Oral Maxillofac Surg; 2000 Feb; 38(1):12-5. PubMed ID: 10783440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral submucous fibrosis patients have altered levels of cytokine production.
    Haque MF; Meghji S; Khitab U; Harris M
    J Oral Pathol Med; 2000 Mar; 29(3):123-8. PubMed ID: 10738939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TNF-alpha inactivation of collagen receptors: implications for fibroblast function and fibrosis.
    Chou DH; Lee W; McCulloch CA
    J Immunol; 1996 Jun; 156(11):4354-62. PubMed ID: 8666807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral submucous fibrosis as a precancerous condition.
    Pindborg JJ; Murti PR; Bhonsle RB; Gupta PC; Daftary DK; Mehta FS
    Scand J Dent Res; 1984 Jun; 92(3):224-9. PubMed ID: 6589738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral submucous fibrosis.
    Pindborg JJ; Sirsat SM
    Oral Surg Oral Med Oral Pathol; 1966 Dec; 22(6):764-79. PubMed ID: 5224185
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral submucous fibrosis in a 4-year-old girl.
    Hayes PA
    Oral Surg Oral Med Oral Pathol; 1985 May; 59(5):475-8. PubMed ID: 3859807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue.
    Kovacs EJ
    Immunol Today; 1991 Jan; 12(1):17-23. PubMed ID: 2015044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.
    Piguet PF; Grau GE; Vassalli P
    Am J Pathol; 1990 Jan; 136(1):103-10. PubMed ID: 1688687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
    Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
    J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
    Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
    Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
    Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis.
    Saso L; Reza A; Ng E; Nguyen K; Lin S; Zhang P; Fantozzi PJ; Armagan G; Romeo U; Cirillo N
    Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of salivary tumor necrosis factor
    Abdul Aziz Shaikh S; Denny E C; Kumarchandra R; Natarajan S; Sunny J; Shenoy N; K P N
    Front Oral Health; 2024; 5():1375162. PubMed ID: 38595736
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.